155 related articles for article (PubMed ID: 32151730)
1. Detection of amorphous-amorphous phase separation in small molecular co-amorphous mixtures with SEM-EDS.
Pajula K; Hyyryläinen J; Koistinen A; Leskinen JTT; Korhonen O
Eur J Pharm Biopharm; 2020 May; 150():43-49. PubMed ID: 32151730
[TBL] [Abstract][Full Text] [Related]
2. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection.
Pajula K; Wittoek L; Lehto VP; Ketolainen J; Korhonen O
Mol Pharm; 2014 Jul; 11(7):2271-9. PubMed ID: 24824610
[TBL] [Abstract][Full Text] [Related]
3. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram.
Pajula K; Taskinen M; Lehto VP; Ketolainen J; Korhonen O
Mol Pharm; 2010 Jun; 7(3):795-804. PubMed ID: 20361760
[TBL] [Abstract][Full Text] [Related]
4. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems.
Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O
Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500
[TBL] [Abstract][Full Text] [Related]
5. Molecular indicators of surface and bulk instability of hot melt extruded amorphous solid dispersions.
Yang Z; Nollenberger K; Albers J; Craig D; Qi S
Pharm Res; 2015 Apr; 32(4):1210-28. PubMed ID: 25270572
[TBL] [Abstract][Full Text] [Related]
6. Detecting different amorphous - Amorphous phase separation patterns in co-amorphous mixtures with high resolution imaging FTIR spectroscopy.
Kilpeläinen T; Ervasti T; Uurasjärvi E; Koistinen A; Ketolainen J; Korhonen O; Pajula K
Eur J Pharm Biopharm; 2022 Nov; 180():161-169. PubMed ID: 36122786
[TBL] [Abstract][Full Text] [Related]
7. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
Altamimi MA; Neau SH
Drug Dev Ind Pharm; 2016 Mar; 42(3):446-455. PubMed ID: 26266965
[TBL] [Abstract][Full Text] [Related]
8. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.
Marsac PJ; Li T; Taylor LS
Pharm Res; 2009 Jan; 26(1):139-51. PubMed ID: 18779927
[TBL] [Abstract][Full Text] [Related]
9. Early stages of drug crystallization from amorphous solid dispersion via fractal analysis based on chemical imaging.
Abreu-Villela R; Schönenberger M; Caraballo I; Kuentz M
Eur J Pharm Biopharm; 2018 Dec; 133():122-130. PubMed ID: 30300718
[TBL] [Abstract][Full Text] [Related]
10. Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions.
Zhang J; Shi Q; Tao J; Peng Y; Cai T
Mol Pharm; 2019 Mar; 16(3):1385-1396. PubMed ID: 30716277
[TBL] [Abstract][Full Text] [Related]
11. Amorphous and Crystalline Particulates: Challenges and Perspectives in Drug Delivery.
Al-Obaidi H; Majumder M; Bari F
Curr Pharm Des; 2017; 23(3):350-361. PubMed ID: 27829335
[TBL] [Abstract][Full Text] [Related]
12. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems.
Meng F; Dave V; Chauhan H
Eur J Pharm Sci; 2015 Sep; 77():106-11. PubMed ID: 26006307
[TBL] [Abstract][Full Text] [Related]
13. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
14. Amorphous-Amorphous Phase Separation in API/Polymer Formulations.
Luebbert C; Huxoll F; Sadowski G
Molecules; 2017 Feb; 22(2):. PubMed ID: 28212300
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
Xiang TX; Anderson BD
J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the thermal phase diagram of amorphous solid dispersions by Flory-Huggins theory.
Zhao Y; Inbar P; Chokshi HP; Malick AW; Choi DS
J Pharm Sci; 2011 Aug; 100(8):3196-3207. PubMed ID: 21416468
[TBL] [Abstract][Full Text] [Related]
17. Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions.
Blaabjerg LI; Bulduk B; Lindenberg E; Löbmann K; Rades T; Grohganz H
J Pharm Sci; 2019 Aug; 108(8):2561-2569. PubMed ID: 30878513
[TBL] [Abstract][Full Text] [Related]
18. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
Aucamp M; Milne M; Liebenberg W
AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Amorphous Drug Stability Predictions Using Easily Calculated, Predicted, and Measured Parameters.
Nurzyńska K; Booth J; Roberts CJ; McCabe J; Dryden I; Fischer PM
Mol Pharm; 2015 Sep; 12(9):3389-98. PubMed ID: 26236939
[TBL] [Abstract][Full Text] [Related]
20. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
Altamimi MA; Neau SH
Drug Dev Ind Pharm; 2016; 42(3):446-55. PubMed ID: 26289001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]